A Bespoke Central Lab Model to Support Vaccine Trials, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how to manage patient samples from enrollment through database lock for vaccine trials. This webinar is part of a series addressing key challenges facing sponsors of clinical trials. In this webinar, attendees the experts will share insider tips on how best to support (and even accelerate!) vaccine trials with LabConnect's bespoke vaccine model: Agile Kit Build and Resupply; High Volume Sample Forecasting and Accessioning; Dynamic Query Processing; and Access to Testing.
TORONTO, Feb. 27, 2024 /PRNewswire-PRWeb/ -- Vaccine trials are unique in that recruitment is often exceptionally high in subjects and accomplished in a very short time. With this, managing patient samples from enrollment through database lock can be especially challenging for vaccine trials.
Aggressive timelines and swift recruitment schedules that usually accompany vaccine trials can strain kit supplies. The sheer volume of patient samples to be processed can present issues when not forecasted appropriately. Investigator sites carry much of the burden if lab sample queries are not managed effectively or if supplies run short. Unless the central lab is accustomed to working with vaccines, they may not have the right model or access to testing to support these special trials.
This webinar is part of a series addressing key challenges facing sponsors of clinical trials. In this webinar, the experts will share insider tips on how best to support (and even accelerate!) vaccine trials with LabConnect's bespoke vaccine model:
- Agile Kit Build and Resupply
- High Volume Sample Forecasting and Accessioning
- Dynamic Query Processing
- Access to Testing
Register for this webinar today to get insider tips on how best to support vaccine trials using LabConnect's bespoke vaccine model.
Join experts from LabConnect, Cindy Markham, Chief Commercial Officer; April Peltier, Senior Director, Site Operations; Laila Esmail, Director, Client Services; Amber Davies, Director, Biospecimen Operations; and Jack Bradley, Executive Director, Business Development, for the live webinar on Wednesday, March 20, 2024, at 10am EDT (3pm CET/EU-Central).
For more information, or to register for this event, visit A Bespoke Central Lab Model to Support Vaccine Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, www.xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/a-bespoke-central-lab-model-to-support-vaccine-trials-upcoming-webinar-hosted-by-xtalks-302072320.html
SOURCE Xtalks


Upcoming Life Sciences Events
- February 2025
- Biotechgate Digital Partnering February 2025
- Zurich: 18th Annual European Life Sciences CEO Forum
- March 2025
- Miami: Investival Showcase USA
Latest company news
MBX Biosciences to Participate in March Investor Conferences